Objective: To ascertain the relative frequencies of the causes of non-traumatic paraparesis and tetraparesis in adults. Design: Survey of patients enrolled prospectively over a 3 year period between 1986 and 1989 and review of their case notes 1 year after enrollment ceased (mean duration of follow up 30 months). Setting: Regional neurosciences centre in the UK serving over three million people in Merseyside and North Wales. Patients: Experienced clinicians from the centre saw most patients in the region with non-traumatic spastic paraparesis or tetraparesis. Primary investigation of patients was by myelography, for which patients were admitted to the centre. 585 consecutive patients with spastic paraparesis or tetraparesis were identi®ed by daily screening of all 2104 patients undergoing myelography or radiculography during the 3 year period, ie selection by the intention to investigate them for myelopathy. Exclusions: age under 15 years, previous myelography for myelopathy. Interventions: None. Main outcome measures: Numbers and proportions of patients with each condition or category of disease. Results: Commonest diagnoses were cervical spondylotic myelopathy (23.6%), extrinsic neoplastic or developmental tumour (16.4%), multiple sclerosis (9.1% rising to 17.8% after MRI of a selected group), and motor neurone disease (4.1%). Diagnosis was uncertain in 27.4%, falling to 18.6% after MRI. Conclusions: This survey shows the pattern of diseases producing non-traumatic myelopathy in the Mersey Region and in North Wales. Changing patterns of referral, investigation in peripheral hospitals and by non neurologically trained practitioners, and increasing use of outpatient MRI for primary investigation may make comparable surveys impossible in the future.
Introduction
Previous surveys of spastic paraparesis or tetraparesis have been retrospective 3, 4, 6, 12, 13 or have concentrated on selected groups such as patients with acute myelopathy 4 or chronic progressive myelopathy. 6, 9, 12 Some surveys have included a high proportion of paediatric (including spina bi®da) or trauma cases. 2 We have carried out a prospective study of a large group of patients recruited at the time of their ®rst investigation for non-traumatic spastic paraparesis or tetraparesis. The study was approved by the institution's ethical committee.
Materials and methods
The Mersey Regional Neurosciences Centre is the only neurological service for over 3 million people in Merseyside and North Wales. During the period of this study it admitted most of the patients in the region requiring investigation for spastic paraparesis or tetraparesis, except patients with acute traumatic spinal lesions who were routinely dealt with elsewhere.
In the 3 year period betwen 1986 and 1989 myelography was the routine primary investigation for possible myelopathy, with selected patients undergoing subsequent CT or MRI of the spine. Each day we examined the day-book in the radiology department and prospectively identi®ed all patients undergoing myelography or radiculography over this period. After perusal of X-ray request forms, review of the notes, and if necessary examination of the patient, all patients were identi®ed who were aged 15 years or more, had signs of a spastic paraparesis or tetraparesis and were undergoing their ®rst myelogram for that condition. We did not personally examine patients in whom it was clear that a consultant neurologist or neurosurgeon had made a clinical diagnosis of spastic paraparesis or tetraparesis.
For this selected group we collected information on clinical features. We recorded the myelogram ®ndings and the diagnosis after further investigation or surgery. One year after the survey was completed we reviewed each patient's notes and revised the ®nal diagnosis if necessary. We did not attempt to in¯uence patient management.
Results
The pattern of admissions did not change between 1986 and 1989.
8 2104 patients underwent myelography or radiculography during this period (Table 1) , 585 (306 men, 279 women) of whom had spastic paraparesis or tetraparesis under investigation for the ®rst time.
The primary anatomical indication for myelography was spastic paraparesis in 450 and spastic tetraparesis in 135. On clinical grounds 366 patients appeared to have an isolated myelopathy, with additional involvement of cranial structures (hemisphere, cerebellum, brain stem or cranial nerves) in 111, or of peripheral root or nerve in 108. In 166 patients the clinician suggested the likely aetiology before myelography (Table 2) , although in many other cases the probable aetiology was implied but not speci®ed.
Results of myelography
The results of myelography appear in Table 3a. Table  3b shows the conclusions drawn on the basis of the clinical picture and results of myelography and basic CSF tests (excluding immunology). The diagnosis remained uncertain in 246/585 (42%) patients ie the largest single group, which included many patients who were eventually found to have multiple sclerosis (MS). Table 4 shows the diagnoses reached after further imaging studies including MRI in a few cases, CT and angiography, neurophysiology including electromyography (EMG), nerve conduction studies and evoked potentials, blood and CSF tests, biopsy or operation. It includes information obtained from the review of case notes a year after case ascertainment was completed.
Final diagnoses
Uncertain diagnosis There were 160 (27.4%) patients in whom the diagnosis remained uncertain before MRI. It is likely that some in this group have MS. Sixty-nine of the 160 cases were under 50 years old and had an isolated, unexplained and clinically de®nite myelopathy with no other complicating systemic disease. They all had MRI and were followed up. They are the subject Primary skeletal disease (n=168/585, 28.7%) This was the largest group with a clear diagnosis, and included 138 (23.8%) patients with cervical spondylotic myelopathy. Eighty-®ve (62%) of these promptly went on to operation. Others may have had surgery at a later date. Four patients had thoracic disc protrusions requiring immediate surgery.
There were 11 (1.9%) patients who had cord deformity related to a congenital or developmental spinal disease such as Arnold-Chiari (3) or KlippelFeil (1) anomalies, tethered cord with thickened ®lum terminale (4), achondroplasia (1), lumbar dysraphism (1) or kyphoscoliosis of uncertain aetiology (1). Many of the 14 patients with syringomyelia also had congenital spinal or foramen magnum anomalies.
Eight (1.4%) patients had cervical cord compression with lesions due to known rheumatoid arthritis; three cases had atlanto-axial instability without evidence of rheumatoid disease. Other acquired skeletal causes of myelopathy included Paget's disease (2), hypophosphataemic rickets (1), and ankylosing spondylitis (1) . Neoplasms A breakdown of the tumour type in the 96/ 585 (16.5%) patients with an extrinsic compressive tumour and the 15/585 (2.6%) patients with an intrinsic tumour is given in Tables 5 and 6 .
Previously known malignancy There were 41/585 (7%) patients with a history or clinical evidence of neoplasia prior to myelography. In only two of these was an independent non-cancerous pathology (cervical spondylotic disease) identi®ed, with no evidence of tumour recurrence or iatrogenic disease. In 24 of the 41, spread or recurrence of neoplasia was con®rmed as the cause of cord compression, though two of these were assumed diagnoses as no de®nitive histology was available. A second primary tumour appeared in three patients. Non-metastatic tumour related myelopathy was diagnosed or strongly suspected in six. Iatrogenic radiation necrosis was eventually blamed in three patients and three others had arachnoiditis related to previous encephalograms. One of these had a possible recurrence of cranial ependymoma which made the cause of the spastic paraparesis uncertain. Parenchymal immune disease (n=61/585, 10.4%) There were 53 patients in whom a diagnosis of clinically probable or clinically de®nite MS was made. 10 A further eight had transverse myelitis of uncertain aetiology (3), encephalomyelitis clearly related to recent viral illness or immunisation (3), SLE (1) or sarcoidosis (1).
Infections (n=14/585, 2.4%) Eight patients had a spinal abscess: staphylococcus aureus was isolated in ®ve, E. coli in one, one had a tuberculoma and one was sterile. There were ®ve patients with positive syphilis serology. One had classical tabes dorsalis, another had infarction of the cord presumed to be caused by meningovascular disease, and a third had CSF changes suggesting active syphilis. It was not clear whether syphilis contributed to the myelopathy in the other two, one of whom may have had yaws. One patient had Creutzfeldt-Jacob disease. The 69 (white, European) patients with pure myelopathy and normal myelograms who were being followed long-term were all negative for HTLV-1. 5 Patients were not tested for HIV.
Neurodegenerative and familial There were 36/585 (6.2%) patients in this group. They had motor neurone disease (24), spinocerebellar degeneration (5), hereditary spastic paraparesis (2), spinal muscular atrophy (2), multi-system atrophy (1), adrenomyeloleukodystrophy (1), and possible corticobasal degeneration (1).
Vascular disease (n=10, 1.7%) Infarction of the cord related to atherosclerotic disease was diagnosed in ®ve patients. In ®ve patients a clinical syndrome mimicking cord disease was eventually attributed to multi-infarct or brainstem cerebrovascular disease.
Metabolic disease There were four patients with mild or moderately severe B12 de®ciency. They were all treated with B12 supplements, but it was not clear whether the B12 de®ciency was relevant to the myelopathy. One had signi®cant coexisting cervical spondylotic cord compression. In all four the ®nal diagnosis was registered as uncertain.
Age pro®les
Age pro®les are given in Figure 1 for patients with cervical spondylotic myelopathy, compressive neoplasms, MS and motor neurone disease. The proportion with MS peaked in the decade 40 ± 49. The proportions with cervical spondylotic myelopathy, neoplasms and motor neurone disease continued to rise until the decade 60 ± 69. The subsequent apparent fall in incidence of these three disorders is probably an artefact of our screening technique in that increasingly elderly patients are less likely to be investigated by myelography. Comparison of the groups with MS and with pure, non-compressive myelopathy (not shown) showed a bulge in the early decades and a relative decline after age 49 for the latter group.
Discussion
Although this was a hospital based survey, the results are probably representative of signi®cant non-traumatic myelopathy in our community. Case ascertainment was prospective and based on the clinically de®ned picture of myelopathy as determined by experienced clinicians. Inclusion in the study was on the basis of intention to investigate for myelopathy. Apart from cases obviously related to trauma which were seen in spinal injury units, signi®cant myelopathy arising in our area would almost always result in referral to one of our clinicians. There could have been overspill to adjacent neurological services, but this would probably aect all causes of myelopathy equally. Patients were routinely investigated in our unit rather than at the referring hospital. As myelography was used as the ®rst choice investigation at the time, all patients who were investigated were detected and entered into the study.
Nevertheless, some patients with myelopathy will not have been included in this study ie patients with mild sensory symptoms suggestive of myelopathy but not severe enough to warrant investigation, and others in whom it was not considered appropriate to undertake myelography because of severe systemic illness or advanced cancer. Not all patients with myelopathy due to known MS or motor neurone disease will have been subjected to myelography.
It should be noted that of the 2104 patients screened, only those with signs consistent with spastic paraparesis or tetraparesis were entered into the study. There were undoubtedly other patients who could have had spinal cord disease without signs of upper motor neurone involvement ± for example, patients with pure root or lower motor neurone signs or symptoms, ataxia, pure bladder dysfunction or pain with no other signs. These cases were not entered.
This was not a survey of isolated myelopathy. Patients with additional neurological features such as cranial nerve or spinal root disease were included. Such features rarely preclude spinal cord disease, and we aimed to generate an overall picture of the causes of non-traumatic myelopathy.
The modern ®rst choice investigation of myelopathy is MRI, and myelography is much less frequently used. It is possible that this shift in practice will reveal diering patterns of myelopathy, but only 18.6% of our patients were left undiagnosed in this survey, and either possible pathology or multiple pathologies were uncovered in some of these.
Reasons for an uncertain ®nal diagnosis
Multiple sclerosis It is likely that many of the patients in whom a ®nal diagnosis could not be con®rmed will eventually develop MS. In previous studies of myelopathy follow up revealed MS in 3% 4 ± 75% 7 depending on the initial case selection, the extent of the diagnostic screen, and the duration of follow up. It is dicult to compare reports because these factors either varied widely in each study or were not discussed.
Motor neurone disease This diagnosis may also be under-represented at the time of myelography and may only become apparent with time. It is important because a number of the patients diagnosed as having other disorders, particularly cervical spondylotic myelopathy, may have motorneurone disease in addition, or even as the sole contributory pathology (Rowland 1992 ). 11 They are likely to fare less well after surgery.
Multiple pathology This category has not been used in previous studies. We encountered diagnostic diculty in many patients because of multiple potentially relevant pathologies. For instance, one patient had possible radiation myelitis after treatment for ankylosing spondylitis, and was also found to have bilateral subdural haematomas. Some patients with signi®cant cervical spondylotic cord compression had a family history or signs such as pes cavus suggesting an associated familial myelopathy, or showed features of MS. There were numerous other combinations which made an unequivocal single diagnosis impossible, so that in 14 such patients the diagnosis remained uncertain. The clinician felt able to decide which was the dominant pathology in other patients who had more than one possible aetiology.
Insucient evidence of causation Thirty patients had suggestive but not diagnostic abnormalities; they included the four who were treated for past or present B12 de®ciency, and two with a history of syphilis which may have been inadequately treated many years earlier. There were six patients with possible ischaemic cerebrovascular or cord disease, ®ve patients with Figure 1 Histogram showing age pro®les for patients with motor neurone disease (MN), multiple sclerosis (MS), compressive tumour (TU) and cervical spondylotic myelopathy (CS). Left axis shows scale for individual conditions, right axis shows scale for line graph of total number of patients in each age group, including all other diagnoses. The lower numbers of patients with MND, TUM and CSM in the decade 70 ± 79 years probably re¯ect both a smaller population and the method of case selection, with a reluctance to pursue myelography in elderly patients. Numbers in the age group 80 ± 89 years were too small to be worth including features suggestive of sporadic familial disease and three with congenital or developmental anomalies not suciently pronounced to be diagnostic.
Not myelopathy Multi-infarct or brain stem cerebrovascular disease (®ve patients), lumbar disc disease (1), and polymyositis (1) were occasionally mistaken for myelopathy and the patient subjected to myelography.
Comparison with previous studies
The only comparable published study is that of Ungar-Sargon, Lovelace and Brust (1980), who carried out a survey of 672 patients admitted to the Columbia Presbyterian Medical Centre over 16 years with spastic paraplegia-paraparesis (SPP) as a prominent ®nding. 13 Their study diered from ours in a number of ways. It was retrospective and a majority (77%) of the group did not have myelography. Patients were not entered on the basis of aǹ intention to investigate', nor was there any information supplied about factors leading to admission. No age ranges were given or limits applied except for patients in whom the diagnosis remained uncertain. Their study group comprised 181 patients with spinal trauma, and 491 others. To allow comparison with our data we have excluded the trauma patients from the following discussion and modi®ed their original ®gures accordingly.
CT and MRI scanning were not available to UngarSargon and colleagues. 13 In our study cranial CT may have in¯uenced case selection in that some patients with intracranial causes of SPP may have been diagnosed without myelography. We would not have recruited these patients. However, CT and (in a few patients) MRI after myelography enabled us to make or exclude some diagnoses with greater certainty.
Ungar-Sargon and co-workers assigned diagnoses to 520 patients`on the basis of history, clinical ®ndings or plain spine radiography without myelography or other further investigations'. 13 It is not clear how the ®nal diagnoses were achieved in many of these cases, or what degree of certainty was required. 108/491 (21%) were diagnosed after investigations which included myelography, spinal angiography, CSF analysis or surgery. In 44/491 (9%), all with`pure' progressive SPP, no diagnosis was reached. This group compares best with the 69/ 585 (12%) of our patients with undiagnosed isolated myelopathy, 1 although our group included patients with monophasic and relapsing disease. Overall, we could not reach a de®nite single diagnosis in 160/585 (27.4%) patients. If the results of MRI scanning in our selected group of 69/585 are included, the number undiagnosed falls to 109 (18.6%).
A diagnosis of cervical spondylotic myelopathy was made in only 15/491 (3%) of the patients studied by Ungar-Sargon et al, 13 compared to 139/585 (24%) of our patients. This striking and signi®cant dierence (Chi-square with Yates' correction, P50.0001) is dicult to explain unless there were major differences in referral patterns. Marshall (1955) 6 found in a retrospective survey that only 5/87 (6%) of his patients with`progressive spastic paraplegia' of middle age had cervical spondylosis, but clearly this was a highly selected group. 6 The proportions of patients with tumours in the two studies were comparable at 14% and 17% respectively. The distribution of tumour type was also similar, with 6/60 (10%) of the patients with a spinal tumour having an intrinsic neoplasm in the New York study, compared to 14/110 (13%) of our patients. Metastatic disease accounted for 35/60 (58%) and 58/110 (53%) respectively. In patients with metastatic disease UngarSargon et al 13 found 5/35 (14%) to be of haemopoietic origin compared to our 16/58 (28%). This dierence is not signi®cant. The primary sites of origin were otherwise similar in the two series. 15/60 (25%) of the American tumour cases had extrinsic tumours of nervous system origin compared to 19/110 (17%) in our series.
Ungar-Sargon and colleagues classi®ed arteriovenous malformation separately, recording 21/491 (4%) diagnosed by tortuous vessels on myelography or by spinal angiography, 13 compared to our ®gure of 6/585 (1%). Other dierences include their ®nding of 10/491 (2%) with arachnoiditis (they did not speci®cally exclude patients with previous or multiple myelograms) compared to 2/585 (0.3%) of our patients, and 10/491 (2%) with amyotrophic lateral sclerosis (ALS) against our 24/585 (4.1%) with motor neurone disease.
There were 4/491 patients with Pott's disease or tuberculosis and no mention is made of other organisms causing spinal abscess. In our 8/585 patients with spinal abscess, ®ve were due to staphylococcus aureus and only one related to tuberculosis. Positive syphilis serology was uncommon in both series, 4/491 versus 5/585, and in both series it was not clear whether the syphilis was the primary pathology in all cases.
Changing patterns of disease
The dierence in the design of the two studies makes it dicult to draw conclusions about changing patterns of disease. The larger proportion left undiagnosed in our study may re¯ect its prospective nature, the shorter period of follow up and diering criteria for diagnosis. The most striking dierence was the higher proportion with cervical spondylotic myelopathy in our study (24% versus 4%), although this could be a referral or selection artefact. In future, changing patterns may arise through new diseases such as HIV-related myelopathy.
Future surveys
The increasing availability of MRI will alter the apparent spectrum of diagnoses in a number of ways. It may help to diagnose conditions such as MS, and to reduce the number of patients in whom the diagnosis remains uncertain. However, more sensitive investigations may also increase the proportion of patients in whom dual pathology is detected, thus making a clear diagnosis more dicult. Indirectly, the threshold for investigation is likely to fall, more patients will be dealt with locally by doctors not speci®cally trained in the neurosciences, and referral patterns will change. These factors suggest that for epidemiological surveys any gain in accuracy of diagnosis using MRI as the primary investigation might be countered by poorer case selection and the loss of the representative overview previously available to regional units. It will not be possible to compensate for this by using diagnosis-related codes from district hospitals because these would permit only retrospective surveys.
Conclusion
This survey shows the pattern of diseases producing non-traumatic myelopathy in Mersey region and North Wales. Case selection was by intention to investigate for myelopathy. A representative sample and high standard of case selection were ensured because most patients with non-traumatic myelopathy were seen at the regional centre. Myelography was the primary investigation, only undertaken after clinical consultation with a fully trained neurologist or neurosurgeon, and all patients undergoing myelography were clinically screened. It is likely to be the last time that such a study can be undertaken, as MRI is now the imaging technique of choice in this situation. In any future comparisons the method of case selection is probably the most important factor to consider.
